Calithera Biosciences, Inc.
CALA
|
$0.04
150.0%
5.3K
|
Health Technology
(0.0% 1d) (150.0% 1m) (22.0% 1y) (0.0% 2d) (0.0% 3d) (0.0% 7d) (-28.37% volume)
Earnings Calendar: 2023-03-30
Market Cap: $ 194,900
http://www.calithera.com
Sec Filling | Patents | 93 employees
(US) Calithera Biosciences, Inc. is a clinical-stage biopharmaceutical company, which focuses on discovering and developing small molecule drugs that target novel and critical metabolic pathways in tumor and cancer-fighting immune cells. It offers programs such as Pipeline, Glutaminase Inhibitor, and Arginase Inhibitor. The company was founded by James A. Wells and Susan M. Molineaux on March 9, 2010 and is headquartered in South San Francisco, CA.
cancer t-cell molecule drugs metabolic ceiling
add to watch list Paper trade email alert is off
Press-releases
Turnstone Biologics Appoints William Waddill to its Board of Directors
Published: 2024-04-16 (Crawled : 13:00) - globenewswire.com
TSBX | $2.69 0.0% 110K
|
|
| O: 2.49%
H: 4.17%
C: -2.78%
PTGX | $25.23 -1.33% -1.35% 390K
|
Health Technology
|
| O: -1.05%
H: 0.38%
C: -0.72%
ARWR | $22.62 0.4% 0.4% 1.3M
|
Health Technology
|
| O: -1.17%
H: 2.57%
C: -0.25%
ANNX | $4.435 -3.27% -3.38% 1.4M
|
Health Technology
|
| O: -3.48%
H: 2.89%
C: -7.67%
Calithera Biosciences Announces Update on Complete Liquidation and Dissolution
Published: 2023-06-29 (Crawled : 20:00) - globenewswire.com
CALA | $0.04 150.0% 5.3K
|
Health Technology
|
| O: -2.86%
H: 0.0%
C: -82.35%
update
Calithera Biosciences Announces Update on Complete Liquidation and Dissolution
Published: 2023-05-19 (Crawled : 20:00) - globenewswire.com
CALA | $0.04 150.0% 5.3K
|
Health Technology
| Email alert
Add to watchlist
update
Repare Therapeutics Appoints Susan Molineaux, Ph.D., to Its Board of Directors
Published: 2023-04-28 (Crawled : 21:00) - biospace.com/
RIGL | $1.06 -4.51% -4.72% 1.2M
|
Health Technology
|
| O: 0.0%
H: 3.13%
C: 0.89%
RPTX 4 | $3.025 -5.76% -6.12% 140K
|
Health Technology
|
| O: 0.33%
H: 1.33%
C: -0.99%
CALA | $0.04 150.0% 5.3K
|
Health Technology
|
| O: -75.0%
H: 350.0%
C: 100.0%
therapeutics
Delisting of Securities of EQONEX LIMITED; Scopus BioPharma Inc.; Peak Bio, Inc.; Statera Biopharma, Inc.; Tricida, Inc.; Arbor Rapha Capital Bioholdings Corp. I; Calithera Biosciences, Inc.; Waitr Holdings Inc.; Allied Healthcare Products, Inc.; and Metacrine, Inc. from The Nasdaq Stock Market
Published: 2023-03-01 (Crawled : 22:00) - globenewswire.com
TCDAQ | $0.01 -24.78% 32K
|
n/a
|
| O: -26.47%
H: 20.0%
C: 6.4%
ASAP 4 | $0.0175 363.43% 2.4M
|
Administrative and Support and ...
|
| O: -0.07%
H: 14.39%
C: 7.21%
NDAQ | $60.075 0.11% 0.11% 2.3M
|
Finance
|
| O: -0.83%
H: 1.85%
C: 1.65%
CALA | $0.04 150.0% 5.3K
|
Health Technology
|
| O: -5.06%
H: 7.0%
C: -16.67%
biopharma market
Calithera Biosciences Announces Board Approval of Complete Liquidation and Dissolution
Published: 2023-01-09 (Crawled : 20:00) - biospace.com/
CALA | $0.04 150.0% 5.3K
|
Health Technology
|
| O: -79.56%
H: 6.76%
C: -10.8%
approval
Calithera Biosciences Reports Third Quarter 2022 Financial Results and Business Update
Published: 2022-11-14 (Crawled : 22:00) - globenewswire.com
CALA | $0.04 150.0% 5.3K
|
Health Technology
|
| O: -8.87%
H: 4.67%
C: -7.39%
financial update results
Calithera Biosciences Shares Progress in Sapanisertib and Mivavotinib Clinical Programs at Upcoming Lung Cancer and Lymphoma Conferences
Published: 2022-07-13 (Crawled : 22:00) - biospace.com/
CALA | $0.04 150.0% 5.3K
|
Health Technology
|
| O: -0.7%
H: 6.02%
C: -4.26%
cancer
Calithera Biosciences Announces First Patient Enrolled in Phase 2 Clinical Trial of Sapanisertib in Relapsed/Refractory NRF2 (NFE2L2)-Mutated Squamous Non-Small Cell Lung Cancer
Published: 2022-07-06 (Crawled : 00:00) - biospace.com/
CALA | $0.04 150.0% 5.3K
|
Health Technology
|
| O: 1.95%
H: 3.45%
C: -0.38%
trial cancer phase 2
Calithera Biosciences Announces 1-for-20 Reverse Stock Split
Published: 2022-06-14 (Crawled : 17:00) - globenewswire.com
CALA | $0.04 150.0% 5.3K
|
Health Technology
|
| O: 1912.92%
H: 3.31%
C: -31.39%
Last 15 days Sec forms
| File Id | Form | Published Date | Transaction Date | Direction | Code | Amount Transacted | Owned Amount |
| 0001395064-23-000040 | 4 | 2023-05-26 | 2023-04-17 | Sell | J | 1000000 | 0 |
Your Today's Watch List
Sign in to create a watchlistGainers vs Losers
| 64% | 36% |
Top 10 Gainers
AGBA | News | $1.02 155.0% 57.94% 120M
|
Finance
ZCMD | $2.86 108.76% 52.1% 2.3M
|
Commercial Services
INVO | $1.555 104.6% 51.13% 5M
|
Health Technology
ISPC | $0.437 105.16% 49.53% 37M
|
Professional, Scientific, and T...
WLGS | News | $0.92 84.0% 45.65% 1.6M
|
OST | $0.499 21.38% 45.26% 1.9M
|
XPON | News | $3.1 60.62% 37.74% 17M
|
TIRX | $0.7 44.39% 30.74% 58M
|
BNTC | News | $6.92 44.17% 30.64% 3.5M
|
Health Technology
GGE | $0.035 19.86% 29.3% 64M
|
Last 48 Hours Insiders Buying
AXR P 2400 | $22.17 2.69% 0.0% 5.5K
|
Finance
|
21:00
QCRH P 118 | $55.405 1.33% 1.31% 54K
|
Finance
|
18:01
VUZI P 7500 | $1.26 3.28% 3.17% 1M
|
Electronic Technology
|
18:00
RMCF | $3.61 2.27% 2.22% 18K
|
Consumer Non-Durables
|
20:10